Emergent and J&J settle dispute over COVID vaccine supplies
Emergent BioSolutions said Monday that Johnson & Johnson has agreed to pay $50 million to settle claims related to a terminated COVID-19 vaccine deal. The company’s shares rose about 2 per cent in extended trading.
ПОПУЛЯРНЫЕ ПОСТЫ
Colombia was the deadliest country for environmentalists in 2023
Сентябрь 11, 2024
Floods inundate northern Vietnam, Typhoon Yagi death toll rises
Сентябрь 11, 2024
Destin Daniel Cretton in talks to direct ‘Spider-Man 4’
Сентябрь 11, 2024
ПОДПИСЫВАЙТЕСЬ НА НАС
ПРЯМАЯ ТРАНСЛЯЦИЯ